In September 1995, the FDA to begin with authorised testosterone transdermal patches (Androderm); quite a few transdermal varieties and brands are now readily available like implants, gels, and topical alternatives. A testosterone buccal system, Striant, was FDA authorised in July 2003; the procedure is a mucoadhesive item that adheres into the buc